Sun Pharma Executive and Leadership Team

Malcolm Brown, the Chief Executive Officer at Sun Pharma, directs the company's overall strategic vision and operational execution. Brown oversees the development and implementation of long-term growth plans, ensuring alignment with Sun Pharma's mission to provide high-quality pharmaceutical formulations and active pharmaceutical ingredients. This leadership position involves guiding all major business units and ensuring cross-functional collaboration to achieve market leadership in specialty generics. Brown's strategic direction is critical for navigating the complex global pharmaceutical landscape and driving innovation in product development. The Chief Executive Officer ensures that all operations adhere to stringent quality standards and regulatory requirements, maintaining Sun Pharma's reputation for excellence. Malcolm Brown's executive oversight extends to fostering a culture of continuous improvement and operational efficiency across the organization, directly impacting the company's financial performance and market standing.

Kal Sundaram, the Chief Executive Officer, America' at Sun Pharma, leads the company's strategic operations and business development across the Americas. Sundaram is responsible for driving revenue growth, expanding market presence, and ensuring operational excellence for Sun Pharma's pharmaceutical formulations and active pharmaceutical ingredients in North and South America. This executive position involves overseeing sales, marketing, and regulatory affairs within the region, adapting global strategies to local market demands. Sundaram's leadership focuses on strengthening Sun Pharma's position as a key player in the American pharmaceutical landscape. The Chief Executive Officer, America' fosters key relationships with healthcare providers, distributors, and regulatory bodies to enhance market access and product adoption. Kal Sundaram's strategic direction is critical for achieving Sun Pharma's growth objectives and delivering high-quality healthcare solutions throughout the Americas.

Zvi Albert, the Chief Financial Officer at Sun Pharma, manages the company's financial strategy and operations. Albert is responsible for financial planning, risk management, and capital allocation, ensuring the fiscal health and sustainable growth of Sun Pharma. This role involves overseeing all accounting functions, treasury operations, and investor relations, providing critical financial insights to support strategic decision-making. Albert's expertise is vital in optimizing financial performance and ensuring compliance with global financial regulations. The Chief Financial Officer plays a key part in securing funding for research and development initiatives and managing mergers and acquisitions. Zvi Albert's leadership ensures robust financial controls and transparent reporting, reinforcing investor confidence and supporting the company's expansion into new markets. Albert drives financial discipline across all departments, contributing directly to Sun Pharma's profitability and long-term viability.

Omesh Sethi, the Vice President & Chief Financial Officer at Sun Pharma, provides critical financial leadership and oversight. Sethi directs financial planning, analysis, and reporting, ensuring the fiscal integrity and strategic financial management of the company's pharmaceutical operations. This executive role involves managing budgets, optimizing resource allocation, and mitigating financial risks across Sun Pharma's diverse product portfolio. Sethi's responsibilities extend to enhancing shareholder value and ensuring compliance with all financial regulations in the markets Sun Pharma serves. The Vice President & Chief Financial Officer collaborates closely with other senior leaders to drive profitable growth and operational efficiency. Omesh Sethi's financial acumen is instrumental in guiding Sun Pharma's investment strategies and maintaining a strong balance sheet, supporting the company's global expansion and commitment to specialty generics.

Jayashree Satagopan, the Global Chief Financial Officer at Sun Pharma, directs the company's worldwide financial operations and strategy. Satagopan is responsible for financial planning, reporting, and capital management across all international markets, ensuring Sun Pharma's fiscal strength and compliance. This executive position involves overseeing treasury functions, investment strategies, and financial risk mitigation to support global growth initiatives. Satagopan's leadership ensures that financial resources are effectively allocated to drive innovation in pharmaceutical formulations and active pharmaceutical ingredients. The Global Chief Financial Officer plays a pivotal role in mergers, acquisitions, and strategic partnerships that expand Sun Pharma's global footprint. Jayashree Satagopan's financial expertise is crucial for maintaining investor confidence and achieving sustainable profitability, reinforcing Sun Pharma's position as a leading specialty generic pharmaceutical company.

Medha Dang, the Manager (Chief Information Officer Office) at Sun Pharma, supports the strategic direction and operational efficiency of the company's information technology functions. Dang facilitates the execution of IT initiatives that enhance Sun Pharma's manufacturing and distribution capabilities for pharmaceutical formulations and active pharmaceutical ingredients. This role involves coordinating projects that improve data management, cybersecurity, and digital infrastructure, ensuring seamless technological integration across global operations. Dang's focus is on enabling business objectives through effective IT solutions and process optimization. The Manager (Chief Information Officer Office) ensures that technology investments align with Sun Pharma's overall business strategy, driving innovation and operational excellence. Medha Dang's contributions are essential for maintaining a secure and advanced technological environment, supporting Sun Pharma's competitive edge in the pharmaceutical industry.

Faried Niamut, the Manager, Quality Assurance & Chief Marketing Officer, Biologics & Pharma Branded at Sun Pharma, leads critical functions in product integrity and market strategy. Niamut oversees the stringent quality assurance processes that ensure the safety and efficacy of Sun Pharma's pharmaceutical formulations and active pharmaceutical ingredients. Concurrently, Niamut drives the marketing initiatives for the Biologics and Branded Pharma segments, focusing on market penetration and brand development. This dual role requires a deep understanding of both regulatory compliance and commercial dynamics. The Manager, Quality Assurance & Chief Marketing Officer, Biologics & Pharma Branded ensures that products meet the highest quality standards while simultaneously executing targeted marketing campaigns to expand market share. Faried Niamut's leadership ensures Sun Pharma's branded products achieve their full commercial potential while maintaining unwavering product quality.

Jaydeep Shah, the Chief Marketing Officer, Consumer Health Business, Sun Pharma, spearheads the marketing strategy for Sun Pharma's consumer health division. Shah directs all marketing efforts aimed at increasing brand awareness, market share, and consumer engagement for Sun Pharma's over-the-counter products and wellness solutions. This role involves developing and executing comprehensive marketing plans, including digital campaigns, product launches, and promotional activities. Shah's focus is on understanding consumer needs and translating them into effective market strategies that drive sales growth. The Chief Marketing Officer, Consumer Health Business, Sun Pharma collaborates with product development and sales teams to ensure market alignment and competitive positioning. Jaydeep Shah's leadership is vital for expanding Sun Pharma's presence in the consumer health sector and delivering accessible healthcare solutions to a broad audience.

Upma Sharma, the Chief Medical Officer at Sun Pharma, directs the company's medical affairs and clinical development strategies. Sharma oversees clinical research, drug safety, and medical information, ensuring that Sun Pharma's pharmaceutical formulations and active pharmaceutical ingredients meet rigorous scientific and regulatory standards. This leadership role involves guiding the clinical trial process, interpreting trial data, and providing medical expertise to support product development and lifecycle management. Sharma's focus is on advancing Sun Pharma's pipeline and ensuring the safe and effective use of its products globally. The Chief Medical Officer collaborates with R&D, regulatory affairs, and commercial teams to align medical strategies with business objectives. Upma Sharma's medical insights are crucial for Sun Pharma's commitment to innovation and patient well-being, reinforcing the company's dedication to improving healthcare outcomes.

Marianela Echeverry, the Rrhh at Sun Pharma, manages the human resources functions critical to supporting Sun Pharma's workforce. Echeverry oversees talent acquisition, employee relations, and organizational development, ensuring a skilled and motivated team is in place to drive the company's mission. This role involves implementing HR policies and programs that foster a positive and productive work environment, aligning with Sun Pharma's commitment to its employees. Echeverry's responsibilities include developing strategies for employee engagement, performance management, and professional growth. The Rrhh ensures that Sun Pharma attracts and retains top talent, essential for innovation in pharmaceutical manufacturing and distribution. Marianela Echeverry's leadership in human resources is fundamental to building a strong organizational culture and supporting Sun Pharma's continued success in the global pharmaceutical market.